KELLEY SHANNON T (General Counsel) sold 2.9% of their position (360.00 shares) of MADRIGAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $155.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/6/2026ACC: 0001628280-26-015763
Officer· General Counsel
Since Mar 2026
+8.68K
Net shares
Net buyer
$155.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
9.04K acquired · 360.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.02K
Price / share
—
Trade value
—
% of position
47.4%
3/4/2026
8.48K→12.50K
Common Stock
Direct
Shares
−360.00
Price / share
$431.94
Trade value
$155.50K
% of position
2.9%
3/6/2026
12.50K→12.14K
Total
Net shares
+3.66K
Net value
-$155.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2026 | A · Award | +4.02K | — | — | 47.4% | 8.48K | 12.50K |
| Common Stock Direct | 3/6/2026 | S · Sale | −360.00 | $431.94 | $155.50K | 2.9% | 12.50K | 12.14K |
| Total | +3.66K | -$155.50K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5.02K shares
Shares
+5.02K
Strike price
434.80
Held after
5.02K
Exercisable
—
3/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5.02K shares | 3/4/2026 | A · Award | +5.02K | 434.80 | — | 5.02K |